Medical Biomimetics Market By Disease Type (Cardiovascular, Orthopedic, Ophthalmology, Dental, Others), By Application (Wound Healing, Tissue Engineering, Drug Delivery, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Description

List of Tables

The global medical biomimetics market size was valued at $35.4 billion in 2021 and is projected to reach $68.9 billion by 2031, growing at a CAGR of 7.2% from 2022 to 2031. Biomimetics is a cutting-edge design idea that uses aspects and processes found in nature to solve challenging human problems. The term "biomimetics" consists of the two ancient Greek words i.e., "bios" and "mimesis," which translate to "life" and "imitate," respectively. Medical biomimetics is a device that draws inspiration from nature to solve complex human problems related to health. Biomimetics is used for wound healing, tissue engineering, and drug delivery. Biomimetic materials can be used to treat and preserve the tooth, cardiac regeneration, enhance natural abilities & restore the function of limbs.

Major factors driving the growth of the medical biomimetics market include a rise in technological advancement in drug delivery, such as the use of nanocapsules/nanospheres, nanocrystals, liposomes, nano lipid carriers/solid lipid nanoparticles, nanosponges and dendrimers based on biomimetics for targeted delivery of the drug. For instance, according to the review article "Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system" published in November 2022, the biological roles of cell membrane surface proteins endow nanoparticles with several functions, such as immune escape, long circulation time, and targeted delivery; therefore, these proteins are being extensively used in the fields of drug delivery. According to the same source, in the biomimetic approach, the erythrocytes membrane is used to coat polymeric nanoparticles in order to reduce macrophage uptake and systemic clearance.

Furthermore, the surge in the prevalence of cardiac diseases propels the demand for bioengineering technology to grow human replacement tissues as next-generation implants such as LifeMatrix tissues drive the growth of the medical biomimetics market. For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, about 697,000 people in the U.S. died from heart disease in 2020. According to the same source, every year, about 805,000 people in the U.S. have a heart attack. Out of these 805,000 people, 605,000 people have a first heart attack and 200,000 happen to people who have already had a heart attack.

In addition, the rise in the trend of biomimetics products, an increase in awareness regarding biomimetics product, an increase in the number of clinical trials of biomimetics product, rise in the discovery & development of effective medical biomimetics product, drives the growth of the medical biomimetics market. For instance, in July 2020, CorNeat KPro, the first synthetic cornea that bio-integrated with the eye wall, received approval to begin a clinical trial at Beilinson Hospital, Israel. The CorNeat KPro implant is designed to replace deformed, scarred, or opacified corneas and is expected to fully rehabilitate the vision of corneally blind patients immediately following implantation. The device's lens, which provides optical quality equivalent to a perfect cornea, integrates with resident ocular tissue using a unique and patented synthetic non-degradable nano-fabric skirt placed under the conjunctiva.

However, the high costs of medical biomimetics, health risks, and complications associated with medical biomimetics are expected to hamper the medical biomimetics market growth. On the contrary, unmet medical demands in developing countries and lucrative opportunities in emerging economies are expected to create immense opportunities for medical biomimetics product manufacturers in the future.

Furthermore, the healthcare business is projected to witness growth, owing to a rise in the technological advancements in orthopedic products, a rise in research in the bioengineering field, and the development of advanced medical biomimetics boosting the growth of the medical biomimetics market.

The medical biomimetics market is segmented on the basis of disease type, application, and region. On the basis of disease type, the market is classified into cardiovascular, orthopedic, ophthalmology, dental, and others. On the basis of application, the market is classified into wound healing, tissue engineering, drug delivery, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major players profiled in the report are: AVINENT Science and Technology, BioHorizons, Blatchford Limited, CorNeat Vision, Curasan, Inc., Keystone Dental Group, Osteopore International Pte Ltd, Otsuka Medical Devices group (Veryan Medical Limited), Swedish Biomimetics 3000 ApS, and Zimmer Biomet.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical biomimetics market analysis from 2021 to 2031 to identify the prevailing medical biomimetics market opportunities.

Market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.

An in-depth analysis of the medical biomimetics market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes an analysis of the regional as well as global medical biomimetics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Disease Type

Ophthalmology
Cardiovascular
Orthopedic
Dental
Others

By Application

Wound Healing
Tissue Engineering
Drug Delivery
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players

AVINENT Science and Technology
CorNeat Vision
Osteopore International Pte Ltd
Curasan, inc.
Biohorizons
Otsuka Medical Devices Co., Ltd.
Swedish Biomimetics 3000 ApS
Keystone Dental Group
Blatchford Limited
Zimmer Biomet Holding Inc.

Product Code: A10865

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. High bargaining power of buyers
- 3.3.3. Low threat of substitutes
- 3.3.4. Low threat of new entrants
- 3.3.5. Moderate intensity of rivalry
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Rise in prevalence and incidence of chronic wounds
  - 3.4.1.2. Rise in prevalence of dental disease
  - 3.4.1.3. Rise in prevalence of heart disease
- 3.4.2. Restraints
  - 3.4.2.1. Strict regulatory rules and high per-unit cost of production
- 3.4.3. Opportunities
  - 3.4.3.1. Increase in R&D and product launch
3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Cardiovascular
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Orthopedic
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Ophthalmology
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
4.5. Dental
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country
4.6. Others
- 4.6.1. Key market trends, growth factors and opportunities
- 4.6.2. Market size and forecast, by region
- 4.6.3. Market share analysis by country

CHAPTER 5: MEDICAL BIOMIMETICS MARKET, BY APPLICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Wound Healing
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Tissue Engineering
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Drug Delivery
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Others
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: MEDICAL BIOMIMETICS MARKET, BY REGION

6.1. Overview
- 6.1.1. Market size and forecast By Region
6.2. North America
- 6.2.1. Key trends and opportunities
- 6.2.2. Market size and forecast, by Disease Type
- 6.2.3. Market size and forecast, by Application
- 6.2.4. Market size and forecast, by country
  - 6.2.4.1. U.S.
  - 6.2.4.1.1. Key market trends, growth factors and opportunities
  - 6.2.4.1.2. Market size and forecast, by Disease Type
  - 6.2.4.1.3. Market size and forecast, by Application
  - 6.2.4.2. Canada
  - 6.2.4.2.1. Key market trends, growth factors and opportunities
  - 6.2.4.2.2. Market size and forecast, by Disease Type
  - 6.2.4.2.3. Market size and forecast, by Application
  - 6.2.4.3. Mexico
  - 6.2.4.3.1. Key market trends, growth factors and opportunities
  - 6.2.4.3.2. Market size and forecast, by Disease Type
  - 6.2.4.3.3. Market size and forecast, by Application
6.3. Europe
- 6.3.1. Key trends and opportunities
- 6.3.2. Market size and forecast, by Disease Type
- 6.3.3. Market size and forecast, by Application
- 6.3.4. Market size and forecast, by country
  - 6.3.4.1. Germany
  - 6.3.4.1.1. Key market trends, growth factors and opportunities
  - 6.3.4.1.2. Market size and forecast, by Disease Type
  - 6.3.4.1.3. Market size and forecast, by Application
  - 6.3.4.2. France
  - 6.3.4.2.1. Key market trends, growth factors and opportunities
  - 6.3.4.2.2. Market size and forecast, by Disease Type
  - 6.3.4.2.3. Market size and forecast, by Application
  - 6.3.4.3. UK
  - 6.3.4.3.1. Key market trends, growth factors and opportunities
  - 6.3.4.3.2. Market size and forecast, by Disease Type
  - 6.3.4.3.3. Market size and forecast, by Application
  - 6.3.4.4. Italy
  - 6.3.4.4.1. Key market trends, growth factors and opportunities
  - 6.3.4.4.2. Market size and forecast, by Disease Type
  - 6.3.4.4.3. Market size and forecast, by Application
  - 6.3.4.5. Spain
  - 6.3.4.5.1. Key market trends, growth factors and opportunities
  - 6.3.4.5.2. Market size and forecast, by Disease Type
  - 6.3.4.5.3. Market size and forecast, by Application
  - 6.3.4.6. Rest of Europe
  - 6.3.4.6.1. Key market trends, growth factors and opportunities
  - 6.3.4.6.2. Market size and forecast, by Disease Type
  - 6.3.4.6.3. Market size and forecast, by Application
6.4. Asia-Pacific
- 6.4.1. Key trends and opportunities
- 6.4.2. Market size and forecast, by Disease Type
- 6.4.3. Market size and forecast, by Application
- 6.4.4. Market size and forecast, by country
  - 6.4.4.1. China
  - 6.4.4.1.1. Key market trends, growth factors and opportunities
  - 6.4.4.1.2. Market size and forecast, by Disease Type
  - 6.4.4.1.3. Market size and forecast, by Application
  - 6.4.4.2. Japan
  - 6.4.4.2.1. Key market trends, growth factors and opportunities
  - 6.4.4.2.2. Market size and forecast, by Disease Type
  - 6.4.4.2.3. Market size and forecast, by Application
  - 6.4.4.3. India
  - 6.4.4.3.1. Key market trends, growth factors and opportunities
  - 6.4.4.3.2. Market size and forecast, by Disease Type
  - 6.4.4.3.3. Market size and forecast, by Application
  - 6.4.4.4. Australia
  - 6.4.4.4.1. Key market trends, growth factors and opportunities
  - 6.4.4.4.2. Market size and forecast, by Disease Type
  - 6.4.4.4.3. Market size and forecast, by Application
  - 6.4.4.5. Rest of Asia-Pacific
  - 6.4.4.5.1. Key market trends, growth factors and opportunities
  - 6.4.4.5.2. Market size and forecast, by Disease Type
  - 6.4.4.5.3. Market size and forecast, by Application
6.5. LAMEA
- 6.5.1. Key trends and opportunities
- 6.5.2. Market size and forecast, by Disease Type
- 6.5.3. Market size and forecast, by Application
- 6.5.4. Market size and forecast, by country
  - 6.5.4.1. Brazil
  - 6.5.4.1.1. Key market trends, growth factors and opportunities
  - 6.5.4.1.2. Market size and forecast, by Disease Type
  - 6.5.4.1.3. Market size and forecast, by Application
  - 6.5.4.2. Saudi Arabia
  - 6.5.4.2.1. Key market trends, growth factors and opportunities
  - 6.5.4.2.2. Market size and forecast, by Disease Type
  - 6.5.4.2.3. Market size and forecast, by Application
  - 6.5.4.3. South Africa
  - 6.5.4.3.1. Key market trends, growth factors and opportunities
  - 6.5.4.3.2. Market size and forecast, by Disease Type
  - 6.5.4.3.3. Market size and forecast, by Application
  - 6.5.4.4. Rest of LAMEA
  - 6.5.4.4.1. Key market trends, growth factors and opportunities
  - 6.5.4.4.2. Market size and forecast, by Disease Type
  - 6.5.4.4.3. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

8.1. Otsuka Medical Devices Co., Ltd.
- 8.1.1. Company overview
- 8.1.2. Key Executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
- 8.1.7. Key strategic moves and developments
8.2. AVINENT Science and Technology
- 8.2.1. Company overview
- 8.2.2. Key Executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
8.3. CorNeat Vision
- 8.3.1. Company overview
- 8.3.2. Key Executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Key strategic moves and developments
8.4. Swedish Biomimetics 3000 ApS
- 8.4.1. Company overview
- 8.4.2. Key Executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
8.5. Osteopore International Pte Ltd
- 8.5.1. Company overview
- 8.5.2. Key Executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.5.6. Business performance
- 8.5.7. Key strategic moves and developments
8.6. Curasan, inc.
- 8.6.1. Company overview
- 8.6.2. Key Executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
8.7. Keystone Dental Group
- 8.7.1. Company overview
- 8.7.2. Key Executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
- 8.7.6. Key strategic moves and developments
8.8. Zimmer Biomet Holding Inc.
- 8.8.1. Company overview
- 8.8.2. Key Executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
- 8.8.6. Business performance
8.9. Biohorizons
- 8.9.1. Company overview
- 8.9.2. Key Executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
8.10. Blatchford Limited
- 8.10.1. Company overview
- 8.10.2. Key Executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio
- 8.10.6. Key strategic moves and developments